康美药业股份有限公司 第十届董事会2026年度第一次临时会议决议公告

Group 1 - The company held its first temporary board meeting of the 2026 fiscal year on January 5, 2026, with all nine directors present, ensuring compliance with relevant laws and regulations [1] - The board approved the proposal to supplement the members of the specialized committees, with a unanimous vote of 9 in favor and no opposition or abstentions [1] - The company announced the appointment of Ms. Yu Yuying as the convener of the Audit Committee and a member of the Nomination Committee, effective immediately until the end of the current board's term [3] Group 2 - Following the completion of the supplementary election, the composition of the specialized committees of the tenth board has been updated [4]